The US$ hits 30-month lows amid growing risk-on sentiment boosted by US election transition stability and ongoing vaccine optimism. Moderna set to file for US and EU clearance for its COVID-19 vaccine. Chinese PMI data today showed China’s economy grew at its fastest pace in 3-years, boosting risk...

US$ remains under pressure as vaccine and US transition optimism drives risk-on sentiment. AstraZeneca eyes extra global vaccine trials as questions mount over its current results, while the UK moves to get the vaccine approved before the EU. The US President said he will leave the White House if Pr...

The US$ consolidates, equity markets ease, while oil prices extend gains ahead of the US Thanksgiving holiday. Risk on appetite remains as the US Presidential-Election transitions smooths out and key cabinet members are named. Equity & currency markets drop slightly as markets take some profits....

The US$ index falls to 2 ½ years lows as vaccine optimism dampens US$ safe haven demand. AstraZeneca-Oxford joins Pfizer and Moderna today when it announced its vaccine can be 70% to 90% effective. Equity, commodity and currencies extend their gains on the vaccine news. In the US virus hospitalizat...

The reality of the current coronavirus conditions vs the vaccine hopes has caused markets to take stock. The US$ edges up from its 29-month lows vs a basket of major currencies, oil and equities are also down on the day. Global coronavirus cases surpass 56mio, while US confirm cases hit 11.5mio and ...

Equity, oil and currency markets stall amid surging coronavirus cases and US political uncertainty. President Elect Biden calls for a stimulus deal in 2020 without compromise and avoids shutdown questions. In the US the coronavirus average 7 day of infections hits 150k and hospitalizations hit a new...